Mohd Imran

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 73

Top Venues

Biomedicines

Molecules (Basel, Switzerland)

Current oncology (Toronto, Ont.)

Cancers

Northern Border University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Northern Border University Oct 29 2013

Saudi Arabia

Assistant Professor & Head :: Pharmaceutical Chemistry,

Ranbaxy Laboratory Limited Aug 04 2008 - Oct 18 2013

India

Research Scientist (Senior Scale) :: Intellectual Property (Patents)

Wockhardt Research Centre Jun 11 2007 - Jul 31 2008

India

Research Scientist :: Intellectual Property (Patents)

Bhawani Shankar Anangpuria Institute of Pharmacy

India

Assistant Professor :: Pharmaceutical Chemistry

KIET School of Pharmacy

India

Senior Lecturer :: Pharmaceutical Chemistry

Jamia Hamdard (Hamdard University)

India

Teaching assistant :: Pharmaceutical Chemistry

Delhi Institute of Pharmaceutical Sciences and Research (University of Delhi)

India

Part-time teacher :: Pharmaceutical Chemistry

Publications

Tafadzwa Dzinamarira, Mazen M Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Abdulaziz Alsharif, Abida Khan, Mehnaz Kamal, Ali A Rabaan, Amal H Alfaraj, Bashayer M AlShehail, Nouf E Alotaibi, Shams M AlShehail, Mohd Imran
Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Sehrish Kakakhel, Abbas Ahmad, Wael A Mahdi, Sultan Alshehri, Sara Aiman, Sara Begum, Sulaiman Shams, Mehnaz Kamal, Mohd Imran, Faiyaz Shakeel, Asifullah Khan
Annotation of Potential Vaccine Targets and Designing of mRNA-Based Multi-Epitope Vaccine against Lumpy Skin Disease Virus via Reverse Vaccinology and Agent-Based Modeling. Bioengineering (Basel, Switzerland) 10 (4) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Mohammed Kanan Alshammari, Eman Yaser Almomen, Kholoud Falah Alshahrani, Shroog Farhan Altwalah, Mehnaz Kamal, May Faiz Al-Twallah, Suheir Hassan Alsanad, Mariam Hassan Al-Batti, Faisal Jarallah Al-Rasheed, Abdulaziz Yousef Alsalamah, Mohammed Bader Alhazza, Faisal Abdu Alasmari, Abida Khan, Mohd Imran
Nano-Enabled Strategies for the Treatment of Lung Cancer: Potential Bottlenecks and Future Perspectives. Biomedicines 11 (2) (2023)
Shuaibu Abdullahi Hudu, Fayig Elmigdadi, Aiman Al Qtaitat, Mazen M Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Magdi Mansour Salih, Adel Alghamdi, Mohammad A Alrofaidi, Abida Khan, Mohd Imran
Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need. Journal of clinical medicine 12 (15) (2023)
Mansour Almuqbil, Sarah Alshaikh, Nura Alrumayh, Fay Alnahdi, Eiman Fallatah, Shahad Almutairi, Mohd Imran, Mehnaz Kamal, Mazen M Almehmadi, Ahad Amer Alsaiari, Wafa Ali Abdulrhman Alqarni, Ali Mohammed Alasmari, Sara Alwarthan, Ali A Rabaan, Moneer E Almadani, Syed Mohammed Basheeruddin Asdaq
Role of Natural Products in the Management of COVID-19: A Saudi Arabian Perspective. Healthcare (Basel, Switzerland) 11 (11) (2023)
Sara Aiman, Ahmad Khuzaim Alzahrani, Fawad Ali, null Abida, Mohd Imran, Mehnaz Kamal, Muhammad Usman, Hamdy Khamees Thabet, Chunhua Li, Asifullah Khan
Comparative Proteomics and Genome-Wide Druggability Analyses Prioritized Promising Therapeutic Targets against Drug-Resistant Leishmania tropica . Microorganisms 11 (1) (2023)
Mohd Imran, null Abida, Nawaf M Alotaibi, Hamdy Khamees Thabet, Jamal Alhameedi Alruwaili, Lina Eltaib, Ahmed Alshehri, Ahad Amer Alsaiari, Mehnaz Kamal, Abdulmajeed Mohammed Abdullah Alshammari
Repurposing Anti-Dengue Compounds against Monkeypox Virus Targeting Core Cysteine Protease. Biomedicines 11 (7) (2023)
Mohd Imran, Mohammed Kanan Alshammari, Mandeep Kumar Arora, Amit Kumar Dubey, Sabya Sachi Das, Mehnaz Kamal, Abdulaziz Saad Abdulrahman Alqahtani, Mohammed Ahmed Yahya Sahloly, Ahmed Hammad Alshammari, Hessah Mohammed Alhomam, Aeshah Mousa Mahzari, Abida Khan, Ali A Rabaan, Tafadzwa Dzinamarira
Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects. Biomedicines 11 (2) (2023)
Ali A Rabaan, Nada A Alasiri, Mohammed Mubarak Aljeldah, Abeer N Alshukairiis, Zainab AlMusa, Wadha A Alfouzan, Abdulmonem A Abuzaid, Aref A Alamri, Hani M Al-Afghani, Nadira Al-Baghli, Nawal Alqahtani, Nadia Al-Baghli, Mashahed Y Almoutawa, Maha Mahmoud Alawi, Mohammed Alabdullah, Neda A Al Bati, Abdulmonem A Alsaleh, Huseyin Tombuloglu, Kovy Arteaga Livias, Tareq Al-Ahdal, Mohammed Garout, Mohd Imran
An Updated Review on Monkeypox Viral Disease: Emphasis on Genomic Diversity. Biomedicines 11 (7) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Shuaibu Abdullahi Hudu, Ahmed S Alshrari, Aiman Al Qtaitat, Mohd Imran
VP37 Protein Inhibitors for Mpox Treatment: Highlights on Recent Advances, Patent Literature, and Future Directions. Biomedicines 11 (4) (2023)
Mohd Imran, Mazen M Almehmadi, Ahad Amer Alsaiari, Mehnaz Kamal, Mohammed Kanan Alshammari, Mohammed Omar Alzahrani, Faisal Khaled Almaysari, Abdulrahman Omar Alzahrani, Ahmed Faraj Elkerdasy, Dinesh Kumar Chellapan
Intranasal Delivery of a Silymarin Loaded Microemulsion for the Effective Treatment of Parkinson's Disease in Rats: Formulation, Optimization, Characterization, and In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Mohammed Kanan Alshammari, Eman Yaser Almomen, Kholoud Falah Alshahrani, Shroog Farhan Altwalah, Mehnaz Kamal, May Faiz Al-Twallah, Suheir Hassan Alsanad, Mariam Hassan Al-Batti, Faisal Jarallah Al-Rasheed, Abdulaziz Yousef Alsalamah, Mohammed Bader Alhazza, Faisal Abdu Alasmari, Abida Khan, Mohd Imran
Nano-Enabled Strategies for the Treatment of Lung Cancer: Potential Bottlenecks and Future Perspectives. Biomedicines 11 (2) (2023)
Muhammad Sarfraz, Mosab Arafat, Syeda Huma H Zaidi, Lina Eltaib, Muhammad Irfan Siddique, Mehnaz Kamal, Abuzer Ali, Syed Mohammed Basheeruddin Asdaq, Abida Khan, Shams Aaghaz, Mohammed Sanad Alshammari, Mohd Imran
Resveratrol-Laden Nano-Systems in the Cancer Environment: Views and Reviews. Cancers 15 (18) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ali A Rabaan, Seham A Al-Shwaikh, Wadha A Alfouzan, Ali M Al-Bahar, Mohammed Garout, Muhammad A Halwani, Hawra Albayat, Norah B Almutairi, Mohammed Alsaeed, Jeehan H Alestad, Maha A Al-Mozaini, Tala M Al Ashgar, Sultan Alotaibi, Abdulmonem A Abuzaid, Yahya Aldawood, Abdulmonem A Alsaleh, Hani M Al-Afghani, Jaffar A Altowaileb, Abeer N Alshukairi, Kovy Arteaga Livias, Kirnpal Kaur Banga Singh, Mohd Imran
A Comprehensive Review on Monkeypox Viral Disease with Potential Diagnostics and Therapeutic Options. Biomedicines 11 (7) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Mohd Imran, Mazen M Almehmadi, Ahad Amer Alsaiari, Mehnaz Kamal, Mohammed Kanan Alshammari, Mohammed Omar Alzahrani, Faisal Khaled Almaysari, Abdulrahman Omar Alzahrani, Ahmed Faraj Elkerdasy, Dinesh Kumar Chellapan
Intranasal Delivery of a Silymarin Loaded Microemulsion for the Effective Treatment of Parkinson's Disease in Rats: Formulation, Optimization, Characterization, and In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Sara Aiman, Ahmad Khuzaim Alzahrani, Fawad Ali, null Abida, Mohd Imran, Mehnaz Kamal, Muhammad Usman, Hamdy Khamees Thabet, Chunhua Li, Asifullah Khan
Comparative Proteomics and Genome-Wide Druggability Analyses Prioritized Promising Therapeutic Targets against Drug-Resistant Leishmania tropica . Microorganisms 11 (1) (2023)
Sehrish Kakakhel, Abbas Ahmad, Wael A Mahdi, Sultan Alshehri, Sara Aiman, Sara Begum, Sulaiman Shams, Mehnaz Kamal, Mohd Imran, Faiyaz Shakeel, Asifullah Khan
Annotation of Potential Vaccine Targets and Designing of mRNA-Based Multi-Epitope Vaccine against Lumpy Skin Disease Virus via Reverse Vaccinology and Agent-Based Modeling. Bioengineering (Basel, Switzerland) 10 (4) (2023)
Muhammad Sarfraz, Abida Khan, Gaber El-Saber Batiha, Muhammad Furqan Akhtar, Ammara Saleem, Basiru Olaitan Ajiboye, Mehnaz Kamal, Abuzer Ali, Nawaf M Alotaibi, Shams Aaghaz, Muhammad Irfan Siddique, Mohd Imran
Nanotechnology-Based Drug Delivery Approaches of Mangiferin: Promises, Reality and Challenges in Cancer Chemotherapy. Cancers 15 (16) (2023)
Ahmed S Alshrari, Shuaibu Abdullahi Hudu, Fayig Elmigdadi, Mohd Imran
The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects. Biomedicines 11 (2) (2023)
Mohammed Kanan Alshammari, Eman Yaser Almomen, Kholoud Falah Alshahrani, Shroog Farhan Altwalah, Mehnaz Kamal, May Faiz Al-Twallah, Suheir Hassan Alsanad, Mariam Hassan Al-Batti, Faisal Jarallah Al-Rasheed, Abdulaziz Yousef Alsalamah, Mohammed Bader Alhazza, Faisal Abdu Alasmari, Abida Khan, Mohd Imran
Nano-Enabled Strategies for the Treatment of Lung Cancer: Potential Bottlenecks and Future Perspectives. Biomedicines 11 (2) (2023)
Ahmed S Alshrari, Shuaibu Abdullahi Hudu, Fayig Elmigdadi, Mohd Imran
The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects. Biomedicines 11 (2) (2023)
Shuaibu Abdullahi Hudu, Ahmed S Alshrari, Aiman Al Qtaitat, Mohd Imran
VP37 Protein Inhibitors for Mpox Treatment: Highlights on Recent Advances, Patent Literature, and Future Directions. Biomedicines 11 (4) (2023)
Ahmed S Alshrari, Shuaibu Abdullahi Hudu, Fayig Elmigdadi, Mohd Imran
The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects. Biomedicines 11 (2) (2023)
Tafadzwa Dzinamarira, Mazen M Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Abdulaziz Alsharif, Abida Khan, Mehnaz Kamal, Ali A Rabaan, Amal H Alfaraj, Bashayer M AlShehail, Nouf E Alotaibi, Shams M AlShehail, Mohd Imran
Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Mohd Imran, Mazen M Almehmadi, Ahad Amer Alsaiari, Mehnaz Kamal, Mohammed Kanan Alshammari, Mohammed Omar Alzahrani, Faisal Khaled Almaysari, Abdulrahman Omar Alzahrani, Ahmed Faraj Elkerdasy, Dinesh Kumar Chellapan
Intranasal Delivery of a Silymarin Loaded Microemulsion for the Effective Treatment of Parkinson's Disease in Rats: Formulation, Optimization, Characterization, and In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Tafadzwa Dzinamarira, Mazen M Almehmadi, Ahad Amer Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Abdulaziz Alsharif, Abida Khan, Mehnaz Kamal, Ali A Rabaan, Amal H Alfaraj, Bashayer M AlShehail, Nouf E Alotaibi, Shams M AlShehail, Mohd Imran
Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Mohd Imran, Mohammed Kanan Alshammari, Mandeep Kumar Arora, Amit Kumar Dubey, Sabya Sachi Das, Mehnaz Kamal, Abdulaziz Saad Abdulrahman Alqahtani, Mohammed Ahmed Yahya Sahloly, Ahmed Hammad Alshammari, Hessah Mohammed Alhomam, Aeshah Mousa Mahzari, Abida Khan, Ali A Rabaan, Tafadzwa Dzinamarira
Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects. Biomedicines 11 (2) (2023)
Sara Aiman, Ahmad Khuzaim Alzahrani, Fawad Ali, null Abida, Mohd Imran, Mehnaz Kamal, Muhammad Usman, Hamdy Khamees Thabet, Chunhua Li, Asifullah Khan
Comparative Proteomics and Genome-Wide Druggability Analyses Prioritized Promising Therapeutic Targets against Drug-Resistant Leishmania tropica . Microorganisms 11 (1) (2023)
Mohd Imran, Mohammed Kanan Alshammari, Mandeep Kumar Arora, Amit Kumar Dubey, Sabya Sachi Das, Mehnaz Kamal, Abdulaziz Saad Abdulrahman Alqahtani, Mohammed Ahmed Yahya Sahloly, Ahmed Hammad Alshammari, Hessah Mohammed Alhomam, Aeshah Mousa Mahzari, Abida Khan, Ali A Rabaan, Tafadzwa Dzinamarira
Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects. Biomedicines 11 (2) (2023)
Mohd Imran, Mazen M Almehmadi, Ahad Amer Alsaiari, Mehnaz Kamal, Mohammed Kanan Alshammari, Mohammed Omar Alzahrani, Faisal Khaled Almaysari, Abdulrahman Omar Alzahrani, Ahmed Faraj Elkerdasy, Dinesh Kumar Chellapan
Intranasal Delivery of a Silymarin Loaded Microemulsion for the Effective Treatment of Parkinson's Disease in Rats: Formulation, Optimization, Characterization, and In Vivo Evaluation. Pharmaceutics 15 (2) (2023)
Ali A Rabaan, Hajir A Al Saihati, Rehab Bukhamsin, Muhammed A Bakhrebah, Majed S Nassar, Abdulmonem A Alsaleh, Yousef N Alhashem, Ammar Y Bukhamseen, Khalil Al-Ruhimy, Mohammed Alotaibi, Roua A Alsubki, Hejji E Alahmed, Saleh Al-Abdulhadi, Fatemah A Alhashem, Ahlam A Alqatari, Ahmed Alsayyah, Ramadan Abdelmoez Farahat, Rwaa H Abdulal, Ali H Al-Ahmed, Mohd Imran, Ranjan K Mohapatra
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction. Current oncology (Toronto, Ont.) 30 (2) (2023)
Mazen M Almehmadi, Mamdouh Allahyani, Ahad Amer Alsaiari, Mohammed Kanan Alshammari, Abrar Saleh Alharbi, Khansa Hamza Hussain, Lojain Ibrahim Alsubaihi, Mehnaz Kamal, Shahad Saleh Alotaibi, Atheer Nasser Alotaibi, Afeefah Awaid Aldhafeeri, Mohd Imran
A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak. Viruses 14 (9) (2022)
Mohd Imran, Mandeep Kumar Arora, Anurag Chaudhary, Shah Alam Khan, Mehnaz Kamal, Manal Mutlaq Alshammari, Raghad Mohammad Alharbi, Nuha Abdullah Althomali, Ibrahim Mohammed Alzimam, Abdullah Ayed Alshammari, Bashair Hamed Alharbi, Amer Mohammad Alshengeti, Abdulmonem A Alsaleh, Shayea A Alqahtani, Ali A Rabaan
MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature. Biomedicines 10 (11) (2022)
Md Jahangir Alam, Ozair Alam, Mohd Javed Naim, Farah Nawaz, Ajay Manaithiya, Mohd Imran, Hamdy Khamees Thabet, Sultan M Alshehri, Mohammed M Ghoneim, Prawez Alam, Faiyaz Shakeel
Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics. Molecules (Basel, Switzerland) 27 (24) (2022)
Mohd Imran, Shah Alam Khan, Abida Khan, Ahmed Subeh Alshrari, Mahmoud Mudawi Eltahir Mudawi, Mohammed Kanan Alshammari, Aishah Ali Harshan, Noufah Aqeel Alshammari
Small molecules as kinetoplastid specific proteasome inhibitors for leishmaniasis: a patent review from 1998 to 2021. Expert opinion on therapeutic patents 32 (5) (2022)
Md Jahangir Alam, Ozair Alam, Mohd Javed Naim, Farah Nawaz, Ajay Manaithiya, Mohd Imran, Hamdy Khamees Thabet, Sultan M Alshehri, Mohammed M Ghoneim, Prawez Alam, Faiyaz Shakeel
Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics. Molecules (Basel, Switzerland) 27 (24) (2022)
Mohammed Kanan Alshammari, Mohammed Khalid Alghazwni, Abrar Saleh Alharbi, Ghayda Ghazi Alqurashi, Mehnaz Kamal, Salman Rahim Alnufaie, Salem Sayer Alshammari, Bandar Ali Alshehri, Rami Hatem Tayeb, Rashad Jameel M Bougeis, Alaa Adel Aljehani, Nawaf M Alotaibi, Abida Abida, Mohd Imran
Nanoplatform for the Delivery of Topotecan in the Cancer Milieu: An Appraisal of its Therapeutic Efficacy. Cancers 15 (1) (2022)
Md Jahangir Alam, Ozair Alam, Ahmad Perwez, Moshahid Alam Rizvi, Mohd Javed Naim, Vegi Ganga Modi Naidu, Mohd Imran, Mohammed M Ghoneim, Sultan M Alshehri, Faiyaz Shakeel
Design, Synthesis, Molecular Docking, and Biological Evaluation of Pyrazole Hybrid Chalcone Conjugates as Potential Anticancer Agents and Tubulin Polymerization Inhibitors. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Syed Mohammed Basheeruddin Asdaq, Shahamah Jomah, Syed Imam Rabbani, Ali Musharraf Alamri, Salman Khalaf Salem Alshammari, Badr Sami Duwaidi, Majed Sadun Alshammari, Abdulhakeem S Alamri, Walaa F Alsanie, Majid Alhomrani, Nagaraja Sreeharsha, Mohd Imran
Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2022 (2022)
Tafadzwa Dzinamarira, Mohd Imran, Claude Mambo Muvunyi
The Management of Infectious Diseases in Comorbidity with Tuberculosis. Medicina (Kaunas, Lithuania) 58 (10) (2022)
Adel Alghamdi, Mansour Almuqbil, Mohammad A Alrofaidi, Abdulhadi S Burzangi, Ali A Alshamrani, Abdullah R Alzahrani, Mehnaz Kamal, Mohd Imran, Sultan Alshehri, Basheerahmed Abdulaziz Mannasaheb, Nasser Fawzan Alomar, Syed Mohammed Basheeruddin Asdaq
Potential Antioxidant Activity of Apigenin in the Obviating Stress-Mediated Depressive Symptoms of Experimental Mice. Molecules (Basel, Switzerland) 27 (24) (2022)
Mohamed A Ashour, Waseem Fatima, Mohd Imran, Mohammed M Ghoneim, Sultan M Alshehri, Faiyaz Shakeel
A Review on the Main Phytoconstituents, Traditional Uses, Inventions, and Patent Literature of Gum Arabic Emphasizing Acacia seyal . Molecules (Basel, Switzerland) 27 (4) (2022)
Mohd Imran, Shah Alam Khan, Abida Khan, Mohammed Kanan Alshammari, Saif M Alkhaldi, Fayez Nafea Alshammari, Mehnaz Kamal, Ozair Alam, Syed Mohammed Basheeruddin Asdaq, A Khuzaim Alzahrani, Shahamah Jomah
Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature. Molecules (Basel, Switzerland) 27 (9) (2022)
Mohd Imran, Waseem Fatima, A Khuzaim Alzahrani, Nida Suhail, Mohammed Kanan Alshammari, Abdulrahman A Alghitran, Fayez Nafea Alshammari, Mohammed M Ghoneim, Sultan M Alshehri, Faiyaz Shakeel
Development of Therapeutic and Prophylactic Zinc Compositions for Use against COVID-19: A Glimpse of the Trends, Inventions, and Patents. Nutrients 14 (6) (2022)
Md Jahangir Alam, Ozair Alam, Mohd Javed Naim, Farah Nawaz, Ajay Manaithiya, Mohd Imran, Hamdy Khamees Thabet, Sultan M Alshehri, Mohammed M Ghoneim, Prawez Alam, Faiyaz Shakeel
Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics. Molecules (Basel, Switzerland) 27 (24) (2022)
Mohammed Faiz Arshad, Aftab Alam, Abdullah Ayed Alshammari, Mohammed Bader Alhazza, Ibrahim Mohammed Alzimam, Md Anish Alam, Gulam Mustafa, Md Salahuddin Ansari, Abdulelah M Alotaibi, Abdullah A Alotaibi, Suresh Kumar, Syed Mohammed Basheeruddin Asdaq, Mohd Imran, Pran Kishore Deb, Katharigatta Narayanaswamy Venugopala, Shahamah Jomah
Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents. Molecules (Basel, Switzerland) 27 (13) (2022)
Adel Alghamdi, Mansour Almuqbil, Mohammad A Alrofaidi, Abdulhadi S Burzangi, Ali A Alshamrani, Abdullah R Alzahrani, Mehnaz Kamal, Mohd Imran, Sultan Alshehri, Basheerahmed Abdulaziz Mannasaheb, Nasser Fawzan Alomar, Syed Mohammed Basheeruddin Asdaq
Potential Antioxidant Activity of Apigenin in the Obviating Stress-Mediated Depressive Symptoms of Experimental Mice. Molecules (Basel, Switzerland) 27 (24) (2022)
Mohammed Kanan Alshammari, Mohammed Khalid Alghazwni, Abrar Saleh Alharbi, Ghayda Ghazi Alqurashi, Mehnaz Kamal, Salman Rahim Alnufaie, Salem Sayer Alshammari, Bandar Ali Alshehri, Rami Hatem Tayeb, Rashad Jameel M Bougeis, Alaa Adel Aljehani, Nawaf M Alotaibi, Abida Abida, Mohd Imran
Nanoplatform for the Delivery of Topotecan in the Cancer Milieu: An Appraisal of its Therapeutic Efficacy. Cancers 15 (1) (2022)
Mohammed Kanan Alshammari, Mohammed Khalid Alghazwni, Abrar Saleh Alharbi, Ghayda Ghazi Alqurashi, Mehnaz Kamal, Salman Rahim Alnufaie, Salem Sayer Alshammari, Bandar Ali Alshehri, Rami Hatem Tayeb, Rashad Jameel M Bougeis, Alaa Adel Aljehani, Nawaf M Alotaibi, Abida Abida, Mohd Imran
Nanoplatform for the Delivery of Topotecan in the Cancer Milieu: An Appraisal of its Therapeutic Efficacy. Cancers 15 (1) (2022)
Mohd Imran, Shah Alam Khan, Mohammed Kanan Alshammari, Ashwaq Muiedh Alqahtani, Turkiah Abdullah Alanazi, Mehnaz Kamal, Talha Jawaid, Mohammed M Ghoneim, Sultan M Alshehri, Faiyaz Shakeel
Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Adel Alghamdi, Mansour Almuqbil, Mohammad A Alrofaidi, Abdulhadi S Burzangi, Ali A Alshamrani, Abdullah R Alzahrani, Mehnaz Kamal, Mohd Imran, Sultan Alshehri, Basheerahmed Abdulaziz Mannasaheb, Nasser Fawzan Alomar, Syed Mohammed Basheeruddin Asdaq
Potential Antioxidant Activity of Apigenin in the Obviating Stress-Mediated Depressive Symptoms of Experimental Mice. Molecules (Basel, Switzerland) 27 (24) (2022)
Md Jahangir Alam, Ozair Alam, Mohd Javed Naim, Farah Nawaz, Ajay Manaithiya, Mohd Imran, Hamdy Khamees Thabet, Sultan M Alshehri, Mohammed M Ghoneim, Prawez Alam, Faiyaz Shakeel
Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics. Molecules (Basel, Switzerland) 27 (24) (2022)
Adel Alghamdi, Mansour Almuqbil, Mohammad A Alrofaidi, Abdulhadi S Burzangi, Ali A Alshamrani, Abdullah R Alzahrani, Mehnaz Kamal, Mohd Imran, Sultan Alshehri, Basheerahmed Abdulaziz Mannasaheb, Nasser Fawzan Alomar, Syed Mohammed Basheeruddin Asdaq
Potential Antioxidant Activity of Apigenin in the Obviating Stress-Mediated Depressive Symptoms of Experimental Mice. Molecules (Basel, Switzerland) 27 (24) (2022)
Mandeep Kumar Arora, Anish Ratra, Syed Mohammed Basheeruddin Asdaq, Ali A Alshamrani, Abdulkhaliq J Alsalman, Mehnaz Kamal, Ritu Tomar, Jagannath Sahoo, Jangra Ashok, Mohd Imran
Plumbagin Alleviates Intracerebroventricular-Quinolinic Acid Induced Depression-like Behavior and Memory Deficits in Wistar Rats. Molecules (Basel, Switzerland) 27 (6) (2022)
Haleema Shahin D H, Rokeya Sultana, Juveriya Farooq, Tahreen Taj, Umaima Farheen Khaiser, Nader Sulaiman Ayyt Alanazi, Mohammed Kanan Alshammari, Mohammad Nazal Alshammari, Firas Hamdan Alsubaie, Syed Mohammed Basheeruddin Asdaq, Abdulmueen A Alotaibi, Abdulrhman Ahmed Alamir, Mohd Imran, Shahamah Jomah
Insights into the Uses of Traditional Plants for Diabetes Nephropathy: A Review. Current issues in molecular biology 44 (7) (2022)
Adel Alghamdi, Mansour Almuqbil, Mohammad A Alrofaidi, Abdulhadi S Burzangi, Ali A Alshamrani, Abdullah R Alzahrani, Mehnaz Kamal, Mohd Imran, Sultan Alshehri, Basheerahmed Abdulaziz Mannasaheb, Nasser Fawzan Alomar, Syed Mohammed Basheeruddin Asdaq
Potential Antioxidant Activity of Apigenin in the Obviating Stress-Mediated Depressive Symptoms of Experimental Mice. Molecules (Basel, Switzerland) 27 (24) (2022)
Mohd Imran, Ahmed Subeh Alshrari, Mohammad Tauseef, Shah Alam Khan, Shuaibu Abdullahi Hudu, Abida Khan
Mucormycosis medications: a patent review. Expert opinion on therapeutic patents 31 (11) (2021)
Archana Adhikari, Syed Mohammed Basheeruddin Asdaq, Maitham A Al Hawaj, Manodeep Chakraborty, Gayatri Thapa, Nihar Ranjan Bhuyan, Mohd Imran, Mohammed Kanan Alshammari, Mohammed Mansour Alshehri, Aishah Ali Harshan, Abeer Alanazi, Bushra Dhuhayyan Alhazmi, Sreeharsha Nagaraja
Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Syed Mohammed Basheeruddin Asdaq, Abu Md Ashif Ikbal, Ram Kumar Sahu, Bedanta Bhattacharjee, Tirna Paul, Bhargab Deka, Santosh Fattepur, Retno Widyowati, Joshi Vijaya, Mohammad Al Mohaini, Abdulkhaliq J Alsalman, Mohd Imran, Sreeharsha Nagaraja, Anroop Balachandran Nair, Mahesh V Attimarad, Katharigatta Narayanaswamy Venugopala
Nanotechnology Integration for SARS-CoV-2 Diagnosis and Treatment: An Approach to Preventing Pandemic. Nanomaterials (Basel, Switzerland) 11 (7) (2021)
Syed Mohammed Basheeruddin Asdaq, N Raghavendra Naveen, Lakshmi Narasimha Gunturu, Kalpana Pamayyagari, Ibrahim Abdullah, Nagaraja Sreeharsha, Mohd Imran, Abdulkhaliq J Alsalman, Maitham A Al Hawaj, Mohammed Al Mohaini, Abdullah A Alsubaie, Khulod D Alanzi, Maha S Alanazi, Amani A Alanazi
Wireless Networking-Driven Healthcare Approaches in Combating COVID-19. BioMed research international 2021 (2021)
Juveriya Farooq, Rokeya Sultana, Tahreen Taj, Syed Mohammed Basheeruddin Asdaq, Abdulkhaliq J Alsalman, Mohammad Al Mohaini, Maitham A Al Hawaj, Mehnaz Kamal, Saad Alghamdi, Mohd Imran, Haleema Shahin, Ruheena Tabasssum
Insights into the Protective Effects of Thymoquinone against Toxicities Induced by Chemotherapeutic Agents. Molecules (Basel, Switzerland) 27 (1) (2021)
Mohd Imran, Mandeep Kumar Arora, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Saleh I Alaqel, Mohammed Kanan Alshammari, Mohammed Mansour Alshehri, Ahmed Subeh Alshrari, Alreshidi Mateq Ali, Ahmed Muteb Al-Shammeri, Bushra Dhuhayyan Alhazmi, Aishah Ali Harshan, Md Tauquir Alam, Abida Khan
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19. Molecules (Basel, Switzerland) 26 (19) (2021)
Mohd Imran, Ahmed Subeh Alshrari, Hamdy Kh Thabet, Abida Khan, Mohammed Afroz Bakht
Synthetic molecules as DprE1 inhibitors: A patent review. Expert opinion on therapeutic patents 31 (8) (2021)
Syed Mohammed Basheeruddin Asdaq, Syed Imam Rabbani, Meshary Alkahtani, Meshal Meshary Aldohyan, Abdullah Mohammad Alabdulsalam, Majed Sadun Alshammari, Saleh Ahmad Alajlan, Aljawharah Binrokan, Yahya Mohzari, Ahmed Alrashed, Mohammed Kanan Alshammari, Mohd Imran, Naira Nayeem
A Patent Review on the Therapeutic Application of Monoclonal Antibodies in COVID-19. International journal of molecular sciences 22 (21) (2021)
Mohd Imran, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Dhanalekshmi Unnikrishnan Meenakshi, Abdulhakeem S Alamri, Walaa F Alsanie, Majid Alhomrani, Yahya Mohzari, Ahmed Alrashed, Mohammed AlMotairi, Eman H Alkhaldi, Abeer K Alorabi, Ahmed Subeh Alshrari, Mohammad Tauseef, Abida Khan, Saleh I Alaqel, Ozair Alam, Mohammed Afroz Bakht
Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Mohd Imran, Shah Alam Khan, Mohammed Kanan Alshammari, Meshal Ayedh Alreshidi, Abeer Abdullah Alreshidi, Rawan Sulaiman Alghonaim, Fayez Aboud Alanazi, Sultan M Alshehri, Mohammed M Ghoneim, Faiyaz Shakeel
Discovery, Development, Inventions, and Patent Trends on Mobocertinib Succinate: The First-in-Class Oral Treatment for NSCLC with EGFR Exon 20 Insertions. Biomedicines 9 (12) (2021)
Syed Mohammed Basheeruddin Asdaq, S Lokaraja, Abdulhakeem S Alamri, Walaa F Alsanie, Majid Alhomrani, Abdulrahman Hadi Almutiri, Sreeharsha Nagaraja, Mohd Imran
Potential Interaction of Fresh Garlic with Metformin during Ischemia-Reperfusion Induced Cardiac Injury in Diabetic Rats. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Abida Khan, Anupama Diwan, Hamdy Kh Thabet, Mohd Imran, Md Afroz Bakht
Discovery of Novel Pyridazine-Based Cyclooxygenase-2 Inhibitors with a Promising Gastric Safety Profile. Molecules (Basel, Switzerland) 25 (9) (2020)

Mohd Imran.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mohd Imran